Misonix to Conduct Q1 FYE 2007 Financial Results Conference Call and Web Cast
13th Nov 2006, 15:57 GMT
Misonix, a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, invites the public to participate in a conference call and Web cast to discuss the Company's Q1 FYE 2007 financial results.
Misonix to Conduct Q1 FYE 2007 Financial Results Conference Call and Web Cast related news:
- Continucare Corp Reports Financial Results for Q1 of FYE 2007 — StratWire - Business of Healthcare NewsFeed
- Nutrition 21 Reports Results for Q1 of FYE 2007 — StratWire - Business of Healthcare NewsFeed
- Misonix Reports Q1 Results for the Period Ended 9/30/2006 — StratWire - Business of Healthcare NewsFeed
- Perceptron Q1 Results for FYE 2007 — StratWire - Business of Healthcare NewsFeed
- Bioniche Reports Q1 Results for FYE 2007 — Bio-Technology News from StratCenter.com
- Tegal Corporation Reports Second Quarter Fiscal 2007 Financial Results — NSTI nanoPRwire
- Perceptron Announces Q1 Results for FYE 2007 and Receipt of 1st Order for Commercial Products — StratWire - Business of Healthcare NewsFeed
- Corgenix Reports Record Revenue for Q1 of FYE 2007 — Operations-Related News from StratCenter.com
- Webcast Alert: InSite Vision Announces Its Q3 FYE 2006 Financial Results Webcast — Partnerships/ Joint Ventures News from StratCenter.com
- Misonix Reports First Quarter Results for the Period Ended September 30, 2006 — RedOrbit News - Health
Latest news from Cardiology News from StratCenter.com:
- Merck says new drug is safer than Vioxx
- WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Volcano Announces Clinical Review of Key Presentations From TCT 2006
- Most defibrillators buried with patients: study
- Esaote Harnesses TX Instruments DSPs to Deliver Next-Generation Medical Diagnostic Systems
- Cerenis Therapeutics Closes $53.5 mln Financing
- November 14th is World Diabetes Day
- Clinical Data and Diagene in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria
- Study Provides Further Support for Cardiovascular Safety of OTC Doses of Naproxen Sodium
- National US Program Gets Americans Dancing for Heart Health